CA1135185A - Agent for the therapy of immunocomplex diseases - Google Patents

Agent for the therapy of immunocomplex diseases

Info

Publication number
CA1135185A
CA1135185A CA000341535A CA341535A CA1135185A CA 1135185 A CA1135185 A CA 1135185A CA 000341535 A CA000341535 A CA 000341535A CA 341535 A CA341535 A CA 341535A CA 1135185 A CA1135185 A CA 1135185A
Authority
CA
Canada
Prior art keywords
agent
reagent
antibody
immunocomplex
immunocomplexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000341535A
Other languages
English (en)
French (fr)
Inventor
Hans-Harald Sedlacek
Friedrich R. Seiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of CA1135185A publication Critical patent/CA1135185A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA000341535A 1978-12-11 1979-12-10 Agent for the therapy of immunocomplex diseases Expired CA1135185A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782853453 DE2853453A1 (de) 1978-12-11 1978-12-11 Mittel zur therapie von immunkomplexerkrankungen
DEP2853453.4 1978-12-11

Publications (1)

Publication Number Publication Date
CA1135185A true CA1135185A (en) 1982-11-09

Family

ID=6056859

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000341535A Expired CA1135185A (en) 1978-12-11 1979-12-10 Agent for the therapy of immunocomplex diseases

Country Status (8)

Country Link
US (1) US4479934A (enExample)
EP (1) EP0012305B1 (enExample)
JP (1) JPS5581817A (enExample)
AT (1) ATE2049T1 (enExample)
CA (1) CA1135185A (enExample)
DE (2) DE2853453A1 (enExample)
IL (1) IL58906A (enExample)
NO (1) NO794019L (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189014A (en) * 1979-12-03 1993-02-23 Cowan Jr Fred M Method of treating cellular Fc receptor mediated hypersensitivity immune disorders
FR2556219B1 (fr) * 1983-12-07 1987-06-26 Merieux Inst Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines
JPH0643343B2 (ja) * 1984-12-28 1994-06-08 株式会社ミドリ十字 免疫調節剤
US4751181A (en) * 1984-12-31 1988-06-14 Duke University Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
US4814433A (en) * 1987-09-16 1989-03-21 Miles Inc. Method for obtaining a papain-free antibody fragment preparation
US5422258A (en) * 1987-12-31 1995-06-06 Tanox Biosystems, Inc. Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5691447A (en) * 1995-03-24 1997-11-25 Tanox Biosystems, Inc. GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
US7425331B2 (en) * 2002-04-10 2008-09-16 Protalex, Inc. Protein A methods of use
US7211258B2 (en) 2002-04-10 2007-05-01 Protalex, Inc. Protein A compositions and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH392780A (de) * 1961-12-07 1965-05-31 Schweiz Rotes Kreuz Verfahren zur Herstellung von intravenös anwendbaren Antikörperpräparaten humanen Ursprungs
US3466368A (en) * 1967-06-02 1969-09-09 Us Health Education & Welfare Cleavage of human gamma globulin by means of cyanogen bromide
GB1508132A (en) * 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
FR2279419A1 (fr) * 1974-07-25 1976-02-20 Merieux Inst Procede de preparation d'immunoglobulines purifiees, immunoglobulines purifiees obtenues et un medicament comprenant ces immunoglobulines purifiees
DE2658334C3 (de) * 1976-12-23 1987-05-07 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Immunglobulinpräparationen mit verminderter Komplementaktivität und ein diese enthaltendes Arzneimittel
DE2846412A1 (de) * 1978-10-25 1980-05-08 Behringwerke Ag Mittel zur behandlung allergischer reaktionen

Also Published As

Publication number Publication date
DE2964386D1 (en) 1983-01-27
EP0012305A1 (de) 1980-06-25
EP0012305B1 (de) 1982-12-22
DE2853453A1 (de) 1980-06-19
JPS5581817A (en) 1980-06-20
US4479934A (en) 1984-10-30
DE2853453C2 (enExample) 1987-11-19
ATE2049T1 (de) 1983-01-15
NO794019L (no) 1980-06-12
IL58906A (en) 1982-11-30
IL58906A0 (en) 1980-03-31

Similar Documents

Publication Publication Date Title
Pierce et al. IMMUNE RESPONSES IN VITRO: III. Development of Primary γM, γG, and γA Plaque-Forming Cell Responses in Mouse Spleen Cell Cultures Stimulated with Heterologous Erythrocytes
US4780401A (en) Novel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applications
US4132769A (en) Cancer antigen, cancer therapy, and cancer diagnosis
Unkeless et al. Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages.
Abramson et al. The interaction between human monocytes and red cells: specificity for IgG subclasses and IgG fragments
DE68925899T2 (de) Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
CA1135185A (en) Agent for the therapy of immunocomplex diseases
EP1394183A1 (en) Purification of polyreactive autoantibodies and uses thereof
US6231856B1 (en) Methods and compositions for treatment of autoimmune diseases
Barandun et al. Clinical tolerance and catabolism of plasmin-treatedγ-globulin for intravenous application
Taylor et al. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model
US5529898A (en) Methods of detecting disorders of the central nervous system by detecting autoantibodies which specifically bind ionotropic glutamate receptors
Bartlow et al. Nonimmunoglobulin C3 activating factor in membranoproliferative glomerulonephritis
Nydegger et al. Polymorphonuclear leukocyte stimulation by immune complexes. Assessment by nitroblue tetrazolium dye reduction
La Via et al. Studies on Fc receptor function: I. IgG-mediated inhibition of B lymphocyte activation by T-dependent and T-independent antigens
Regnault et al. Specific removal of transthyretin from plasma of patients with familial amyloidotic polyneuropathy: optimization of an immunoadsorption procedure
Stigbrand et al. A new specific method for measuring S-100B in serum
Vartlcovski et al. Anti‐platelet and Anti‐DNA IgM in waldenström macroglobulinemia and ITP
EP0205352A2 (en) Monoclonal anti-human IgG4 antibodies, their production and use
Evans et al. In vitro modulation of anti-DNA secreting peripheral blood mononuclear cells of lupus patients by anti-idiotypic antibody of pooled human intravenous immune globulin
Croissant et al. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein
Morioka et al. Herpetiform pemphigus‐like skin lesions induced by D‐penicillamine
McDonald Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice
Magilavy et al. Intravenous gamma globulin in the management of patients with hypogammaglobulinemia
Ropars et al. Human IgE response to the administration of blood components

Legal Events

Date Code Title Description
MKEX Expiry